Ins2 deficiency augments spontaneous HLA-A*0201-restricted T Cell responses to insulin

Irene Jarchum, Teresa P. DiLorenzo

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Type 1 diabetes results from the autoimmune destruction of insulin-producing β cells by T cells specific for β cell Ags, including insulin. In humans, the non-MHC locus conferring the strongest disease susceptibility is the insulin gene, and alleles yielding lower thymic insulin expression are predisposing. We sought to incorporate this characteristic into an HLA-transgenic model of the disease and to determine the influence of reduced thymic insulin expression on CD8+ T cell responses to preproinsulin. We examined NOD.Ins2-/- mice, which do not express insulin in the thymus and show accelerated disease, to determine whether they exhibit quantitative or qualitative differences in CD8+ T cell responses to preproinsulin. We also generated NOD.Ins2-/- mice expressing type 1 diabetes-associated HLA-A*0201 (designated NOD.β2m -/-.HHD.Ins2-/-) in an effort to obtain an improved humanized disease model. We found that CD8+ T cell reactivity to certain insulin peptides was more readily detected in NOD.Ins2-/- mice than in NOD mice. Furthermore, the proportion of insulin-reactive CD8 + T cells infiltrating the islets of NOD.Ins2-/- mice was increased. NOD.β2m-/-.HHD.Ins2-/- mice exhibited rapid onset of disease and had an increased proportion of HLA-A*0201- restricted insulin-reactive T cells, including those targeting the clinically relevant epitope Ins B10-18. Our results suggest that insulin alleles that predispose to type 1 diabetes in humans do so, at least in part, by facilitating CD8+ T cell responses to the protein. We propose the NOD.β2m-/-.HHD.Ins2-/- strain as an improved humanized disease model, in particular for studies seeking to develop therapeutic strategies targeting insulin-specific T cells.

Original languageEnglish (US)
Pages (from-to)658-665
Number of pages8
JournalJournal of Immunology
Volume184
Issue number2
DOIs
StatePublished - Jan 15 2010

Fingerprint

Insulin
T-Lymphocytes
Type 1 Diabetes Mellitus
HLA-A*02:01 antigen
Alleles
Inbred NOD Mouse
Disease Susceptibility
Thymus Gland
Epitopes
Peptides
Genes
Proteins

ASJC Scopus subject areas

  • Immunology
  • Medicine(all)

Cite this

Ins2 deficiency augments spontaneous HLA-A*0201-restricted T Cell responses to insulin. / Jarchum, Irene; DiLorenzo, Teresa P.

In: Journal of Immunology, Vol. 184, No. 2, 15.01.2010, p. 658-665.

Research output: Contribution to journalArticle

@article{58907cd223a740268bf8013d52c7dc3d,
title = "Ins2 deficiency augments spontaneous HLA-A*0201-restricted T Cell responses to insulin",
abstract = "Type 1 diabetes results from the autoimmune destruction of insulin-producing β cells by T cells specific for β cell Ags, including insulin. In humans, the non-MHC locus conferring the strongest disease susceptibility is the insulin gene, and alleles yielding lower thymic insulin expression are predisposing. We sought to incorporate this characteristic into an HLA-transgenic model of the disease and to determine the influence of reduced thymic insulin expression on CD8+ T cell responses to preproinsulin. We examined NOD.Ins2-/- mice, which do not express insulin in the thymus and show accelerated disease, to determine whether they exhibit quantitative or qualitative differences in CD8+ T cell responses to preproinsulin. We also generated NOD.Ins2-/- mice expressing type 1 diabetes-associated HLA-A*0201 (designated NOD.β2m -/-.HHD.Ins2-/-) in an effort to obtain an improved humanized disease model. We found that CD8+ T cell reactivity to certain insulin peptides was more readily detected in NOD.Ins2-/- mice than in NOD mice. Furthermore, the proportion of insulin-reactive CD8 + T cells infiltrating the islets of NOD.Ins2-/- mice was increased. NOD.β2m-/-.HHD.Ins2-/- mice exhibited rapid onset of disease and had an increased proportion of HLA-A*0201- restricted insulin-reactive T cells, including those targeting the clinically relevant epitope Ins B10-18. Our results suggest that insulin alleles that predispose to type 1 diabetes in humans do so, at least in part, by facilitating CD8+ T cell responses to the protein. We propose the NOD.β2m-/-.HHD.Ins2-/- strain as an improved humanized disease model, in particular for studies seeking to develop therapeutic strategies targeting insulin-specific T cells.",
author = "Irene Jarchum and DiLorenzo, {Teresa P.}",
year = "2010",
month = "1",
day = "15",
doi = "10.4049/jimmunol.0903414",
language = "English (US)",
volume = "184",
pages = "658--665",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "2",

}

TY - JOUR

T1 - Ins2 deficiency augments spontaneous HLA-A*0201-restricted T Cell responses to insulin

AU - Jarchum, Irene

AU - DiLorenzo, Teresa P.

PY - 2010/1/15

Y1 - 2010/1/15

N2 - Type 1 diabetes results from the autoimmune destruction of insulin-producing β cells by T cells specific for β cell Ags, including insulin. In humans, the non-MHC locus conferring the strongest disease susceptibility is the insulin gene, and alleles yielding lower thymic insulin expression are predisposing. We sought to incorporate this characteristic into an HLA-transgenic model of the disease and to determine the influence of reduced thymic insulin expression on CD8+ T cell responses to preproinsulin. We examined NOD.Ins2-/- mice, which do not express insulin in the thymus and show accelerated disease, to determine whether they exhibit quantitative or qualitative differences in CD8+ T cell responses to preproinsulin. We also generated NOD.Ins2-/- mice expressing type 1 diabetes-associated HLA-A*0201 (designated NOD.β2m -/-.HHD.Ins2-/-) in an effort to obtain an improved humanized disease model. We found that CD8+ T cell reactivity to certain insulin peptides was more readily detected in NOD.Ins2-/- mice than in NOD mice. Furthermore, the proportion of insulin-reactive CD8 + T cells infiltrating the islets of NOD.Ins2-/- mice was increased. NOD.β2m-/-.HHD.Ins2-/- mice exhibited rapid onset of disease and had an increased proportion of HLA-A*0201- restricted insulin-reactive T cells, including those targeting the clinically relevant epitope Ins B10-18. Our results suggest that insulin alleles that predispose to type 1 diabetes in humans do so, at least in part, by facilitating CD8+ T cell responses to the protein. We propose the NOD.β2m-/-.HHD.Ins2-/- strain as an improved humanized disease model, in particular for studies seeking to develop therapeutic strategies targeting insulin-specific T cells.

AB - Type 1 diabetes results from the autoimmune destruction of insulin-producing β cells by T cells specific for β cell Ags, including insulin. In humans, the non-MHC locus conferring the strongest disease susceptibility is the insulin gene, and alleles yielding lower thymic insulin expression are predisposing. We sought to incorporate this characteristic into an HLA-transgenic model of the disease and to determine the influence of reduced thymic insulin expression on CD8+ T cell responses to preproinsulin. We examined NOD.Ins2-/- mice, which do not express insulin in the thymus and show accelerated disease, to determine whether they exhibit quantitative or qualitative differences in CD8+ T cell responses to preproinsulin. We also generated NOD.Ins2-/- mice expressing type 1 diabetes-associated HLA-A*0201 (designated NOD.β2m -/-.HHD.Ins2-/-) in an effort to obtain an improved humanized disease model. We found that CD8+ T cell reactivity to certain insulin peptides was more readily detected in NOD.Ins2-/- mice than in NOD mice. Furthermore, the proportion of insulin-reactive CD8 + T cells infiltrating the islets of NOD.Ins2-/- mice was increased. NOD.β2m-/-.HHD.Ins2-/- mice exhibited rapid onset of disease and had an increased proportion of HLA-A*0201- restricted insulin-reactive T cells, including those targeting the clinically relevant epitope Ins B10-18. Our results suggest that insulin alleles that predispose to type 1 diabetes in humans do so, at least in part, by facilitating CD8+ T cell responses to the protein. We propose the NOD.β2m-/-.HHD.Ins2-/- strain as an improved humanized disease model, in particular for studies seeking to develop therapeutic strategies targeting insulin-specific T cells.

UR - http://www.scopus.com/inward/record.url?scp=76249103112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76249103112&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.0903414

DO - 10.4049/jimmunol.0903414

M3 - Article

C2 - 19966211

AN - SCOPUS:76249103112

VL - 184

SP - 658

EP - 665

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 2

ER -